Patient Survival After Kidney Transplantation: Important Role of Graft-sustaining Factors as Determined by Predictive Modeling Using Random Survival Forest Analysis

被引:23
|
作者
Scheffner, Irina [1 ]
Gietzelt, Matthias [2 ,3 ]
Abeling, Tanja [1 ]
Marschollek, Michael [2 ,3 ]
Gwinner, Wilfried [1 ]
机构
[1] Hannover Med Sch, Dept Nephrol, Hannover, Germany
[2] TU Braunschweig, Peter L Reichertz Inst Med Informat, Braunschweig, Germany
[3] Hannover Med Sch, Carl Neuberg Str 1, D-30625 Hannover, Germany
关键词
URINARY-TRACT-INFECTIONS; RENAL-TRANSPLANTATION; RISK-FACTORS; RECIPIENTS; MORTALITY; POSTTRANSPLANT; PHENOTYPES; FAILURE; DEATH;
D O I
10.1097/TP.0000000000002922
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Identification of the relevant factors for death can improve patient's individual risk assessment and decision making. A well-documented patient cohort (n = 892) in a renal transplant program with protocol biopsies was used to establish multivariable models for risk assessment at 3 and 12 months posttransplantation by random survival forest analysis. Methods. Patients transplanted between 2000 and 2007 were observed for up to 11 years. Loss to follow-up was negligible (n = 15). A total of 2251 protocol biopsies and 1214 biopsies for cause were performed. All rejections and clinical borderline rejections in protocol biopsies were treated. Results. Ten-year patient survival was 78%, with inferior survival of patients with graft loss. Using all pre- and posttransplant variables until 3 and 12 months (n = 65), the obtained models showed good performance to predict death (concordance index: 0.77-0.78). Validation with a separate cohort of patients (n = 349) showed a concordance index of 0.76 and good discrimination of risks by the models, despite substantial differences in clinical variables. Random survival forest analysis produced robust models over a wide range of parameter settings. Besides well-established risk factors like age, cardiovascular disease, type 2 diabetes, and graft function, posttransplant urinary tract infection and rejection treatment were important factors. Urinary tract infection and rejection treatment were not specifically associated with death due to infection or malignancy but correlated strongly with inferior graft function and graft loss. Conclusions. The established models indicate the important areas that need special attention in the care of renal transplant patients, particularly modifiable factors like graft rejection and urinary tract infection.
引用
收藏
页码:1095 / 1107
页数:13
相关论文
共 44 条
  • [41] Assessing the influence of graft loss on 4-year patient survival after simultaneous pancreas-kidney transplantation: Kaplan-Meier versus Competing Risk Analysis model
    Villanueva, Lucia Alejandra Alfaro
    Meirelles Junior, Roberto
    Rangel, erika Bevilaqua
    Modelli, Luis Gustavo
    Viana, Laila Almeida
    Cristelli, Marina Pontello
    Requiao-Moura, Lucio
    Foresto, Renato Demarchi
    Tedesco-Silva, Helio
    Pestana, Jose Medina
    CLINICAL TRANSPLANTATION, 2024, 38 (04)
  • [42] Low-dose Rituximab and Thymoglobulin Induction With Steroid-free Maintenance Immunosuppression and Protocol Biopsies Improves Long-term Patient and Graft Survival After Kidney Transplantation: Survival and Safety Outcomes in More Than 1100 Patients From a Single Center
    Pathak, Vivek
    Madhavan, Devdas
    Narayanasamy, Kuppurajan
    Kumar, Sampath
    Ramalingam, Vasanthan
    Sengodagounder, Balasundaram
    Bodonyi-Kovacs, Gabor
    TRANSPLANTATION DIRECT, 2019, 5 (08):
  • [43] Delayed graft function in pediatric deceased donor kidney transplantation: Donor-related risk factors and impact on two-yr graft function and survival: A single-center analysis
    Cesca, Eleonora
    Ghirardo, Giulia
    Kiblawi, Rim
    Murer, Luisa
    Gamba, Piergiorgio
    Zanon, Giovanni Franco
    PEDIATRIC TRANSPLANTATION, 2014, 18 (04) : 357 - 362
  • [44] Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMT
    Frankiewicz, Andrzej
    Peczynski, Christophe
    Giebel, Sebastian
    Harrington, Alenca
    Socie, Gerard
    Niederwieser, Dietger
    Scheid, Christoph
    Bornhaeuser, Martin
    Kroeger, Nicolaus
    Elmaagacli, Ahmet
    Afanasyev, Boris
    Dreger, Peter
    Roessig, Claudia
    Blaise, Didier
    Kratz, Christian
    Yakoub-Agha, Ibrahim
    Kremens, Bernhard
    Niemeyer, Charlotte Marie
    Wulf, Gerald
    Blau, Igor
    Penack, Olaf
    Greinix, Hildegard
    Basak, Grzegorz W.
    FRONTIERS IN IMMUNOLOGY, 2020, 11